CDC seeks bird flu diagnostic tests

Dec 05, 2006

The U.S. Centers for Disease Control and Prevention has awarded $11.4 million for development of new, rapid diagnostic tests for avian influenza.

The CDC said the contracts went to four companies working to develop diagnostic tests that physicians and field epidemiologists could use to quickly and accurately test patients for avian influenza H5N1 and other emerging viruses, receiving results within 30 minutes.

In providing the funding, the CDC said it hopes commercialization of the products can occur within two to three years.

Existing point-of-care tests can only determine if the patient is infected with seasonal influenza viruses A or B, but cannot identify avian influenza H5N1. To test for H5N1, patient samples currently must be sent to one of about 100 designated labs nationwide that can perform specialized testing. The process can take four to 24 hours to complete, depending on shipping of samples.

The companies receiving CDC funding are Cepheid Inc. of Sunnyvale, Calif.; Iquum Inc. of Marlborough, Mass.; MesoScale Discovery of Gaithersburg, Md.; and Nanogen Inc. of San Diego.

Copyright 2006 by United Press International

Explore further: Salmonella and Campylobacter show significant levels of resistance to common antimicrobials in humans and animals

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Home walking program improves erectile function after MI

Feb 27, 2015

(HealthDay)—For men with recent acute myocardial infarction, a home-based walking program is associated with a reduction in reported erectile dysfunction (ED), according to a study published in the March ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.